Karma Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Karma Biotechnologies's estimated annual revenue is currently $2.5M per year.
- Karma Biotechnologies's estimated revenue per employee is $826,667
Employee Data
- Karma Biotechnologies has 3 Employees.
- Karma Biotechnologies grew their employee count by -77% last year.
Karma Biotechnologies's People
| Name | Title | Email/Phone |
|---|
Karma Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Karma Biotechnologies?
Therapies for autoimmune diseases are stuck in the 20th century – physicians can only alleviate a patient's symptoms by crippling their entire immune system. Karma was founded by a team of immune engineers, nanotech scientists, and company builders to create a better solution. We're developing Xavines™, off-the-shelf therapeutics designed to shut down only the self-attacking rogue immune cells while leaving the rest of the immune system functional.
keywords:N/A
N/A
Total Funding
3
Number of Employees
$2.5M
Revenue (est)
-77%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Los Angeles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0M | 3 | 0% | $7.6M |
#2 | $0.2M | 3 | -67% | N/A |
#3 | $0.2M | 3 | N/A | N/A |
#4 | $0.2M | 3 | N/A | N/A |
#5 | $0M | 3 | 0% | $8.5M |